What Is the Most Complete Longevity Blood Panel?

What Is a Longevity Blood Panel?

A longevity blood panel goes beyond a standard annual blood test by including biomarkers that are more sensitive to early-stage risk — the kind that can be present years before symptoms appear. Rather than simply checking whether you are ill, it aims to identify where risk is accumulating and where intervention could make the most difference.

That said, no blood test can measure biological age with precision or guarantee a longer life. What a well-constructed panel can do is give you a clearer picture of your cardiovascular risk, metabolic health, inflammation burden, and organ function — and help you prioritise the changes most likely to improve your healthspan. Learn more in our complete guide to longevity.

The most useful longevity panels focus on markers that are both measurable and actionable. More testing is not always better. In practice, a focused set of high-value biomarkers will outperform a long list of exotic tests that are difficult to interpret or that don’t change clinical decisions.

Core Biomarkers: Where to Start

The foundation of any longevity panel covers the areas most strongly linked to premature death and loss of healthspan: cardiovascular risk, metabolic function, inflammation, liver health, and kidney function. These are the markers that are most evidence-backed, most actionable, and most relevant for the majority of people.

Cardiovascular Risk Markers

Standard lipid panels measure LDL cholesterol, HDL cholesterol, and triglycerides. However, for longevity purposes, ApoB is a more precise marker of cardiovascular risk because it reflects the total number of atherogenic particles in circulation — including small dense LDL that standard tests can miss. Evidence increasingly supports ApoB as a superior predictor of cardiovascular events compared to LDL-C alone.

Lipoprotein(a), or Lp(a), is another cardiovascular marker worth measuring at least once. It is largely genetically determined and does not respond significantly to lifestyle changes. As a result, knowing your Lp(a) level helps you understand your baseline cardiovascular risk independently of lifestyle factors — something a standard lipid panel cannot reveal. For a focused explanation, see our article on what Lipoprotein(a) is and why it matters.

Metabolic Markers

Fasting glucose, fasting insulin, and HbA1c together provide a picture of insulin sensitivity and glycaemic control. Metabolic dysfunction is one of the most common drivers of accelerated ageing, and these markers can reveal risk well before a diagnosis of type 2 diabetes. In many people, insulin resistance is detectable years — sometimes decades — before blood glucose rises into the diabetic range.

Inflammation Markers

High-sensitivity CRP (hs-CRP) is the most practical inflammation marker for routine use. Chronic low-grade inflammation is strongly associated with cardiovascular disease, metabolic dysfunction, and accelerated biological ageing. Importantly, hs-CRP is widely available, inexpensive, and responds to lifestyle interventions — making it both a useful risk indicator and a progress marker.

Liver Function

Standard liver enzymes — ALT, AST, and particularly GGT (gamma-glutamyl transferase) — provide useful information about liver health and metabolic stress. GGT is of particular interest in a longevity context because elevated levels may reflect not just alcohol burden but also oxidative stress, non-alcoholic fatty liver disease, and broader metabolic risk. Research suggests that even mildly elevated GGT within the normal range is associated with increased all-cause mortality in some populations.

Kidney Function

Creatinine and eGFR (estimated glomerular filtration rate) are the standard markers for kidney function. However, Cystatin C offers an important additional layer of information. It is less affected by muscle mass than creatinine, meaning it can detect early kidney function decline in people whose creatinine appears normal. Evidence suggests Cystatin C may be a more sensitive predictor of cardiovascular and all-cause mortality risk in some groups.

Advanced Markers Worth Knowing About

Beyond the core panel, several additional biomarkers are increasingly discussed in the context of longevity medicine. These can add value in specific contexts, but they are generally harder to interpret and less immediately actionable than the markers above.

Inflammatory Cytokines: IL-6 and TNF-alpha

Interleukin-6 (IL-6) and TNF-alpha are pro-inflammatory cytokines that play a central role in the chronic low-grade inflammation associated with ageing — a process sometimes called “inflammaging.” Both are associated with increased risk of cardiovascular disease, metabolic dysfunction, and age-related decline.

However, these markers are more specialised than hs-CRP. They fluctuate more readily in response to acute stress, illness, or recent exercise, which makes interpretation more challenging. In most routine contexts, hs-CRP remains the more practical first-line inflammation marker. IL-6 and TNF-alpha are most useful for deeper investigation when routine markers suggest inflammation but the source is unclear.

Hormonal and Metabolic Markers

Thyroid function (TSH, free T3, free T4), sex hormones (testosterone, oestrogen, SHBG), and DHEA-S are relevant to energy, body composition, cognitive function, and overall vitality. These are worth assessing when symptoms suggest hormonal imbalance, but they are not universally necessary as a first-line longevity screen.

Homocysteine

Elevated homocysteine is associated with increased cardiovascular and cognitive risk. It is relatively inexpensive to test and may be elevated due to nutritional deficiencies in B vitamins — a modifiable factor, which makes it reasonably actionable when elevated.

Epigenetic and Advanced Ageing Tests

Epigenetic clocks and other biological age tests attempt to estimate how quickly cells are ageing relative to chronological age. These are an evolving area of research. Current evidence suggests they can provide useful population-level insights, but their clinical utility for individual decision-making remains limited. They should be understood as investigative tools, not definitive measures of biological age.

Similarly, direct markers of mitochondrial function and telomere length are scientifically interesting but not yet standardised or consistently actionable in a clinical setting.

How to Use Your Results

The purpose of a longevity blood panel is not to collect numbers — it is to guide decisions. Results should translate into a clear set of priorities: improving ApoB through diet and, where indicated, medication; tightening glucose control through nutrition and exercise; reducing hs-CRP through lifestyle change; supporting liver and kidney health; and maintaining consistency over time.

For most people, the highest-value step is ensuring the core markers are in a healthy range before exploring advanced biomarkers. Chasing marginal improvements in specialised tests while ignoring elevated ApoB or poor insulin sensitivity is unlikely to meaningfully improve outcomes.

Repeat testing every six to twelve months is a reasonable approach for tracking change. However, single results should be interpreted with caution — short-term fluctuations in markers like CRP or homocysteine are common and do not necessarily reflect a meaningful trend.

Working with a clinician experienced in preventive or longevity medicine can help ensure results are interpreted in context and that any interventions are appropriately targeted. Our hub page on longevity blood biomarkers covers how to prioritise across all key marker categories.

Frequently Asked Questions

References and Resources

The following sources provide useful background on longevity biomarkers, advanced blood testing, and healthy ageing research:

Conclusion

A well-designed longevity blood panel is one of the most practical tools available for understanding where your health risks lie and what to prioritise. The most valuable panels focus on cardiovascular risk markers like ApoB and Lp(a), metabolic markers like fasting insulin and HbA1c, inflammation markers like hs-CRP, and organ-function markers like GGT and Cystatin C. Advanced tests such as IL-6, TNF-alpha, and epigenetic clocks can add context in specific situations, but they should complement — not replace — these evidence-based fundamentals. Ultimately, the goal is not to accumulate data but to translate results into clear, targeted actions that support longer, healthier ageing.